Cost-effectiveness of hepatitis A/B vaccination in the private sector.
Jacobs
R Jake
RJ
Meyerhoff
Allen S
AS
D003362:Cost-Benefit Analysis; D006506:Hepatitis A / Q000191:economics / Q000517:prevention & control*; D006509:Hepatitis B / Q000191:economics / Q000517:prevention & control*; D006801:Humans; D017149:Private Sector; D014481:United States; D014611:Vaccination / Q000191:economics*; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage*
D014761:Viral Hepatitis Vaccines